Abstract:
BioForce Nanosciences,Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc.(OTC Bulletin Board: BFNH.OB), announced that it exceeded its 2006 goal forshipping up to 20 of its cutting-edge Nano eNabler(TM) molecular printersto prestigious institutions across the globe. BioForce exceeded its goal bytwo units by year end. These pilot placements of the Company's patentedNano eNabler device at centers of research excellence, allow theentrepreneurial researchers at those centers to act as "early adopters" ofBioForce's practical tools and technologies.

"With the shipment of these 22 Nano eNabler molecular printers," saysBioForce Product Manager Michael Lynch, "BioForce is now essentiallypartnering with an impressive group of innovators working in the micro andnanotechnology fields. Several groups have already expressed a desire toseek funds to convert their placement into a purchase." Kerry Frey, BioForce's chief operating officer, says, "BioForceNanosciences is positioned between two very exciting markets-nanotechnologyand the life sciences. We strongly believe our Nano eNabler system willchange how research is conducted in laboratories across the world." Heexplains that the ease of use and practicality provided by the Nano eNablersystem, establish a path from laboratory to industry. Institutions where recent placements have taken place:

About BioForce NanosciencesBioForce Nanosciences, Inc. is a wholly owned subsidiary of BioForceNanosciences Holdings, Inc. (OTC Bulletin Board: BFNH.OB). BioForceNanosciences is a unique company entering into commercialization with overa decade of research and accomplishment in the field of bionanotechnology.BioForce has demonstrated the ability to take a product from concept tocommercial sale. For more information, visit http://www.bioforcenano.com. This news release contains forward-looking information that may beaffected by certain risks and uncertainties, including those risks anduncertainties described in the Company's most recent filings with theSecurities and Exchange Commission. The Company's actual results coulddiffer materially from such forward-looking statements. We assume no dutyto update these statements at any future date.